The Company's subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc. Revenue in CAD (TTM)14.32m Net income in CAD-2.03m Incorporated2010 Employees-- LocationLSL Pharma Group Inc540, rue d'Avaugour, Office 1800BOUCHERVILLE J4B 0G6CanadaCAN Phone+1 (...
manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms, as well as high-quality sterile ophthalmic pharmaceuticals. For further information, please visit the following websiteswww.groupelslpharma.com,www.laboratoirelsl.comandwww...
manufacturing and distribution of high-quality natural health products and dietary supplements in solid dosage forms, as well as high quality sterile ophthalmic pharmaceutical products. For more information, please visitwww.groupelslpharma.com,www.laboratoi...
LSL Pharma Group Inc. is pleased to announce that the Company has closed the second tranche of its brokered private placement through the issuance of 99,500 unsecured convertible debentures at a price of $10 per Debenture for gross proceeds of $995,000. BOUCHERVILLE, Québec,...
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today reported its financial results for the first quarter of fiscal year 2024 ended on March 31, 2024.